000 | 01862 a2200565 4500 | ||
---|---|---|---|
005 | 20250515201624.0 | ||
264 | 0 | _c20100310 | |
008 | 201003s 0 0 eng d | ||
022 | _a1546-1696 | ||
024 | 7 |
_a10.1038/nbt.1595 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhou, Yinghui | |
245 | 0 | 0 |
_aChimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomas. _h[electronic resource] |
260 |
_bNature biotechnology _cJan 2010 |
||
300 |
_a71-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdenocarcinoma _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aChimera _xmetabolism |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEmbryonic Stem Cells _xdrug effects |
650 | 0 | 4 |
_aErbB Receptors _xmetabolism |
650 | 0 | 4 |
_aLung Neoplasms _xmetabolism |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 |
_aMutation _xgenetics |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 |
_aPiperazines _xpharmacology |
650 | 0 | 4 |
_aProto-Oncogene Proteins p21(ras) _xmetabolism |
650 | 0 | 4 |
_aQuinazolines _xpharmacology |
650 | 0 | 4 |
_aRespiratory Insufficiency _xmetabolism |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
700 | 1 | _aRideout, William M | |
700 | 1 | _aZi, Tong | |
700 | 1 | _aBressel, Angela | |
700 | 1 | _aReddypalli, Shailaja | |
700 | 1 | _aRancourt, Rebecca | |
700 | 1 | _aWoo, Jin-Kyeung | |
700 | 1 | _aHorner, James W | |
700 | 1 | _aChin, Lynda | |
700 | 1 | _aChiu, M Isabel | |
700 | 1 | _aBosenberg, Marcus | |
700 | 1 | _aJacks, Tyler | |
700 | 1 | _aClark, Steven C | |
700 | 1 | _aDepinho, Ronald A | |
700 | 1 | _aRobinson, Murray O | |
700 | 1 | _aHeyer, Joerg | |
773 | 0 |
_tNature biotechnology _gvol. 28 _gno. 1 _gp. 71-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/nbt.1595 _zAvailable from publisher's website |
999 |
_c19404527 _d19404527 |